Impact of intratumoral heterogeneity of breast cancer tissue on quantitative metabolomics using high‐resolution magic angle spinning 1H NMR spectroscopy

High‐resolution magic angle spinning (HR MAS) nuclear magnetic resonance (NMR) spectroscopy is increasingly being used to study metabolite levels in human breast cancer tissue, assessing, for instance, correlations with prognostic factors, survival outcome or therapeutic response. However, the impact of intratumoral heterogeneity on metabolite levels in breast tumor tissue has not been studied comprehensively. More specifically, when biopsy material is analyzed, it remains questionable whether one biopsy is representative of the entire tumor. Therefore, multi‐core sampling (n = 6) of tumor tissue from three patients with breast cancer, followed by lipid (0.9‐ and 1.3‐ppm signals) and metabolite quantification using HR MAS 1H NMR, was performed, resulting in the quantification of 32 metabolites. The mean relative standard deviation across all metabolites for the six tumor cores sampled from each of the three tumors ranged from 0.48 to 0.74. This was considerably higher when compared with a morphologically more homogeneous tissue type, here represented by murine liver (0.16–0.20). Despite the seemingly high variability observed within the tumor tissue, a random forest classifier trained on the original sample set (training set) was, with one exception, able to correctly predict the tumor identity of an independent series of cores (test set) that were additionally sampled from the same three tumors and analyzed blindly. Moreover, significant differences between the tumors were identified using one‐way analysis of variance (ANOVA), indicating that the intertumoral differences for many metabolites were larger than the intratumoral differences for these three tumors. That intertumoral differences, on average, were larger than intratumoral differences was further supported by the analysis of duplicate tissue cores from 15 additional breast tumors. In summary, despite the observed intratumoral variability, the results of the present study suggest that the analysis of one, or a few, replicates per tumor may be acceptable, and supports the feasibility of performing reliable analyses of patient tissue.

[1]  U. Hofmann,et al.  Physiologically-based modelling in mice suggests an aggravated loss of clearance capacity after toxic liver damage , 2017, Scientific Reports.

[2]  J. Rahnenführer,et al.  Metabolic profiling of ob/ob mouse fatty liver using HR-MAS 1H-NMR combined with gene expression analysis reveals alterations in betaine metabolism and the transsulfuration pathway , 2017, Analytical and Bioanalytical Chemistry.

[3]  Atsushi Arakawa,et al.  Ki67 Heterogeneity in Estrogen Receptor–Positive Breast Cancers , 2016, International journal of surgical pathology.

[4]  J. Choi,et al.  Intratumoral Agreement of High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopic Profiles in the Metabolic Characterization of Breast Cancer , 2016, Medicine.

[5]  T. Bathen,et al.  Impact of Freezing Delay Time on Tissue Samples for Metabolomic Studies , 2016, Front. Oncol..

[6]  G. Bethune,et al.  Detecting intratumoral heterogeneity in routine breast-HER2 testing: low yield of testing multiple blocks. , 2015, Annals of diagnostic pathology.

[7]  Daniel Raftery,et al.  Can NMR solve some significant challenges in metabolomics? , 2015, Journal of magnetic resonance.

[8]  Do-Hyun Nam,et al.  Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells , 2015, Genome Biology.

[9]  T. Bathen,et al.  Metabolic characterization of triple negative breast cancer , 2014, BMC Cancer.

[10]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[11]  Jan Böttger,et al.  Protocols for staining of bile canalicular and sinusoidal networks of human, mouse and pig livers, three-dimensional reconstruction and quantification of tissue microarchitecture by image processing and analysis , 2014, Archives of Toxicology.

[12]  A. Vincent-Salomon,et al.  Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma , 2014, British Journal of Cancer.

[13]  J. Choi,et al.  Magnetic Resonance Metabolic Profiling of Breast Cancer Tissue Obtained with Core Needle Biopsy for Predicting Pathologic Response to Neoadjuvant Chemotherapy , 2013, PloS one.

[14]  M. Pisanu,et al.  Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer , 2013, British Journal of Cancer.

[15]  Geert Postma,et al.  Feasibility of MR Metabolomics for Immediate Analysis of Resection Margins during Breast Cancer Surgery , 2013, PloS one.

[16]  R. Roy,et al.  Magic angle spinning NMR spectroscopic metabolic profiling of gall bladder tissues for differentiating malignant from benign disease , 2013, Metabolomics.

[17]  J. Choi,et al.  HR-MAS MR Spectroscopy of Breast Cancer Tissue Obtained with Core Needle Biopsy: Correlation with Prognostic Factors , 2012, PloS one.

[18]  T. Bathen,et al.  Lactate and glycine—potential MR biomarkers of prognosis in estrogen receptor‐positive breast cancers , 2012, NMR in biomedicine.

[19]  P. Lønning,et al.  Predicting long‐term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling , 2012, NMR in biomedicine.

[20]  P. Lønning,et al.  Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy , 2012, BMC Cancer.

[21]  W. Moon,et al.  An HR-MAS MR Metabolomics Study on Breast Tissues Obtained with Core Needle Biopsy , 2011, PloS one.

[22]  T. Sørlie,et al.  Merging transcriptomics and metabolomics - advances in breast cancer profiling , 2010, BMC Cancer.

[23]  A. Børresen-Dale,et al.  Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models , 2010, BMC Cancer.

[24]  Marc K Halushka,et al.  Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer. , 2010, Human pathology.

[25]  Matthias Hermes,et al.  Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration , 2010, Proceedings of the National Academy of Sciences.

[26]  P. Carroll,et al.  Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR‐MAS spectroscopy , 2010, NMR in biomedicine.

[27]  A. Nassar,et al.  Intratumoral Heterogeneity of Immunohistochemical Marker Expression in Breast Carcinoma: A Tissue Microarray-based Study , 2010, Applied immunohistochemistry & molecular morphology : AIMM.

[28]  T. D’alfonso,et al.  Accurately Assessing HER-2/neu Status in Needle Core Biopsies of Breast Cancer Patients in the Era of Neoadjuvant Therapy: Emerging Questions and Considerations Addressed , 2010, The American journal of surgical pathology.

[29]  T. Bathen,et al.  Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics. , 2010, Journal of proteome research.

[30]  T. Bathen,et al.  Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy , 2010, NMR in biomedicine.

[31]  P. N. Rao,et al.  Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer , 2009, Modern Pathology.

[32]  T. Bathen,et al.  High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer , 2009 .

[33]  Franklyn A Howe,et al.  An investigation of human brain tumour lipids by high‐resolution magic angle spinning 1H MRS and histological analysis , 2008, NMR in biomedicine.

[34]  T. Bathen,et al.  MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status , 2007, Breast Cancer Research and Treatment.

[35]  Leo L. Cheng,et al.  Evaluation of Tissue Metabolites with High Resolution Magic Angle Spinning MR Spectroscopy Human Prostate Samples After Three-Year Storage at −80 °C , 2007, Biomarker insights.

[36]  P. Carroll,et al.  Quantitative analysis of prostate metabolites using 1H HR‐MAS spectroscopy , 2006, Magnetic resonance in medicine.

[37]  I. Ellis,et al.  The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast , 2006, Journal of Clinical Pathology.

[38]  T. Bathen,et al.  Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters , 2006, NMR in biomedicine.

[39]  Leo L. Cheng,et al.  Proton high‐resolution magic angle spinning NMR analysis of fresh and previously frozen tissue of human prostate , 2003, Magnetic resonance in medicine.

[40]  B. Sitter,et al.  High‐resolution magic angle spinning MRS of breast cancer tissue , 2002, NMR in biomedicine.

[41]  Jonathan V. Sweedler,et al.  High-Resolution NMR Spectroscopy of Sample Volumes from 1 nL to 10 μL , 1999 .

[42]  L. Barantin,et al.  Concentration Measurement by Proton NMR Using the ERETIC Method. , 1999, Analytical chemistry.

[43]  Barbara L. Smith,et al.  Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. , 1998, Journal of magnetic resonance.

[44]  D. Middleton,et al.  The effect of sample freezing on proton magic‐angle spinning NMR spectra of biological tissue , 1998, Magnetic resonance in medicine.

[45]  P. Lundberg,et al.  1H NMR determination of urinary betaine in patients with premature vascular disease and mild homocysteinemia. , 1995, Clinical chemistry.

[46]  T. Bathen,et al.  HR MAS MR spectroscopy in metabolic characterization of cancer. , 2011, Current topics in medicinal chemistry.

[47]  K. Polyak,et al.  Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.

[48]  Andy Liaw,et al.  Classification and Regression by randomForest , 2007 .

[49]  S. Holm A Simple Sequentially Rejective Multiple Test Procedure , 1979 .